1

Hyperphosphatemia Drugs Market Size, Scope, Growth 2024-2032

News Discuss 
The global hyperphosphatemia drugs market size reached US$ 4.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.8 Billion by 2032, exhibiting a growth rate (CAGR) of 7.07% during 2024-2032. The rising prevalence of end stage kidney disease (ESKD), considerable rise in the geriatric population that is susceptible to developing chronic ailments and the inc... https://www.imarcgroup.com/hyperphosphatemia-drugs-market

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story